CIK 0001665988 · Accelerated filer<br>Emerging growth company
Bioventus Inc.
Sign in to watch- Ticker
- BVS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 810980861
- Phone
- (919) 474-6700
- Business address
- 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM, NC, 27703
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-04-10 | CHURCH KATRINA J SVP & Chief Compliance Officer | Option exercise | +4,300 | 56,840 | ||
| 2025-04-10 | CHURCH KATRINA J SVP & Chief Compliance Officer | Option exercise · Restricted Stock Units | −4,300 | 8,600 | ||
| 2025-03-24 | Singleton Mark Leonard SVP & CFO | Sale 10b5-1 | −5,479 | $9.79 | $54K | 131,963 |
| 2025-03-21 | Singleton Mark Leonard SVP & CFO | Option exercise | +18,625 | 137,442 | ||
| 2025-03-21 | Singleton Mark Leonard SVP & CFO | Option exercise · Restricted Stock Units | −18,625 | 18,625 | ||
| 2025-03-17 | CHURCH KATRINA J SVP & Chief Compliance Officer | Sale 10b5-1 | −1,018 | $9.75 | $10K | 52,540 |
| 2025-03-17 | D'Adamio Anthony SVP & General Counsel | Sale 10b5-1 | −2,615 | $9.75 | $25K | 124,449 |
| 2025-03-14 | Claypoole Robert E President and CEO | Grant or award · Restricted Stock Units | +134,000 | 134,000 | ||
| 2025-03-14 | Claypoole Robert E President and CEO | Grant or award · Stock Option (Right to Buy) | +153,000 | 153,000 | ||
| 2025-03-14 | Singleton Mark Leonard SVP & CFO | Grant or award · Restricted Stock Units | +54,000 | 54,000 | ||
| 2025-03-14 | Singleton Mark Leonard SVP & CFO | Grant or award · Stock Option (Right to Buy) | +61,000 | 61,000 | ||
| 2025-03-14 | D'Adamio Anthony SVP & General Counsel | Grant or award · Restricted Stock Units | +35,000 | 35,000 | ||
| 2025-03-14 | D'Adamio Anthony SVP & General Counsel | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2025-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Grant or award · Restricted Stock Units | +14,000 | 14,000 | ||
| 2025-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Grant or award · Stock Option (Right to Buy) | +16,000 | 16,000 | ||
| 2025-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Option exercise | +3,456 | 53,558 | ||
| 2025-03-14 | CHURCH KATRINA J SVP & Chief Compliance Officer | Option exercise · Restricted Stock Units | −3,456 | 3,455 | ||
| 2025-03-14 | D'Adamio Anthony SVP & General Counsel | Option exercise | +8,886 | 127,064 | ||
| 2025-03-14 | D'Adamio Anthony SVP & General Counsel | Option exercise · Restricted Stock Units | −8,886 | 8,886 | ||
| 2025-02-18 | Singleton Mark Leonard SVP & CFO | Sale 10b5-1 | −6,498 | $10.19 | $66K | 118,817 |
Page 7 of 22 · 437 trades